{{Chembox
| Name = PD-137889
<!-- Images -->
| ImageFile = PD137889_structure.png
| ImageSize = 
| ImageAlt =
<!-- Names -->
| IUPACName = (4aR)-''N''-Methyl-1,2,3,4,9,9a-hexahydro-4a''H''-fluoren-4a-amine
| OtherNames =
<!-- Sections -->
| Section1 = {{Chembox Identifiers
| CASNo = 
| PubChem = 10104280
| ChemSpiderID = 8279807
| SMILES = c12c(cccc1)C3(NC)CCCCC3C2
| InChI=1S/C14H19N/c1-15-14-9-5-4-7-12(14)10-11-6-2-3-8-13(11)14/h2-3,6,8,12,15H,4-5,7,9-10H2,1H3
| InChIKey = KQLIVVYSTDBTMZ-UHFFFAOYSA-N
  }}
| Section2 = {{Chembox Properties
| Formula = 
| C=14 | H=19 | N=1
| MolarMass = 
| Appearance = 
| Density = 
| MeltingPt = 
| BoilingPt = 
| Solubility = 
  }}
| Section3 = {{Chembox Hazards
| MainHazards =
| FlashPt =
| AutoignitionPt =
  }}
}}
'''PD-137889''' (''N''-methylhexahydrofluorenamine) is a chemical compound that is active as an [[NMDA receptor antagonist]] in the [[central nervous system]] at roughly 30 times the potency of the "flagship" of its class, [[ketamine]],<ref>{{cite journal|pmid=8459395|title=Synthesis and pharmacological evaluation of hexahydrofluorenamines as noncompetitive antagonists at the N-methyl-D-aspartate receptor|journal=J Med Chem|year=1993|volume=36|issue=6|pages=654–70}}</ref> and substitutes for [[phencyclidine]] in animal studies.<ref>Nicholson KL, Balster RL. Evaluation of the phencyclidine-like discriminative stimulus effects of novel NMDA channel blockers in rats. ''Psychopharmacology (Berl)''. 2003 Nov;170(2):215-24. {{PMID|12851738}} doi: 10.1007/s00213-003-1527-6</ref><ref>Bigge CF. Structural requirements for the development of potent N-methyl-D-aspartic acid (NMDA) receptor antagonists. ''Biochemical Pharmacology'' 1993; 45(8):1547–1561. doi:10.1016/0006-2952(93)90294-7</ref><ref>Bigge CF, Malone TC. Agonists, Antagonists and Modulators of the N-methyl-D-aspartic acid (NMDA) and α-amino-3-hydroxy-5-methyl-4-isoxazolepropanoic acid (AMPA) Subtypes of Glutamate Receptors. ''Current Opinion On Therapeutic Patents'' 1993; 3(7):951-989. doi: 10.1517/13543776.3.7.951</ref> It has a putative half-life of over ten hours. K''<sub>i</sub>'' [<sup>3</sup>H]TCP{{efn|[<sup>3</sup>H]N-[1-(2-thienyl)cyclohex-yl]piperidine}} binding = 27&nbsp;[[nanomolar|nM]] versus ketamine's K''<sub>i</sub>'' = 860&nbsp;nM.<ref>[http://patft.uspto.gov/netacgi/nph-Parser?d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=4837226.PN.&OS=PN/4837226&RS=PN/4837226 Polycyclic amine derivatives useful as cerebrovascular agents] United States Patent; Coughenour, et al. Family ID: 22686445 Appl. #07/186,834</ref>

==See also==
*[[Aptiganel]]
*[[Dizocilpine]]
*[[Fourphit]]
*[[Metaphit]]
*[[Selfotel]]

==References==
{{Reflist}}
{{notelist}}

{{Ionotropic glutamate receptor modulators}}

[[Category:Dissociative drugs]]
[[Category:General anesthetics]]
[[Category:NMDA receptor antagonists]]
[[Category:Sedatives]]


{{nervous-system-drug-stub}}